Table 1.
Patient characteristics.
| Treatment group | |||||||
|---|---|---|---|---|---|---|---|
| Clopidogrel (n = 20) | Prasugrel (n = 15) | Ticagrelor (n = 21) | |||||
| Median | IQR | Median | IQR | Median | IQR | P-value | |
| Age, years | 64 | 55–71 | 61 | 55–65 | 64 | 52–65 | 0.503 |
| Male, n (%) | 18 | (75%) | 12 | (80%) | 17 | (81%) | 0.129 |
| BMI | 27 | 26–29 | 29 | 26–31 | 29 | 27–30 | 0.218 |
| Blood pressure, sytolic, mmHg | 130 | 127–145 | 133 | 121–150 | 136 | 120–150 | 0.913 |
| Blood pressure, diastolic, mmHg | 80 | 79–82 | 80 | 66–97 | 80 | 70–94 | 0.969 |
| Clinical presentation, NSTEMI (n, %) | 8 | (40%) | 7 | (47%) | 12 | (57%) | 0.271 |
| Diabetes (n, %) | 2 | (10%) | 2 | (13%) | 6 | (29%) | 0.119 |
| Hyperlipidemia (n, %) | 12 | (60%) | 8 | (53%) | 12 | (57%) | 0.857 |
| Hypertension (n, %) | 13 | (65%) | 12 | (80%) | 15 | (71%) | 0.623 |
| Smoking (n, %) | 6 | (30%) | 4 | (53%) | 10 | (48%) | 0.156 |
| Former smoker | 6 | (30%) | 7 | (47%) | 2 | (9.5%) | |
| Family history (n, %) | 11 | (55%) | 8 | (53%) | 12 | (57%) | 0.974 |